As the Director of Engineering at Merck, Amy Baniewicz leverages over two decades of experience in the pharmaceutical industry to drive innovation and operational excellence. In her current role, she leads the Raw Materials Center of Excellence, where she is instrumental in enhancing the quality...
As the Director of Engineering at Merck, Amy Baniewicz leverages over two decades of experience in the pharmaceutical industry to drive innovation and operational excellence. In her current role, she leads the Raw Materials Center of Excellence, where she is instrumental in enhancing the quality and efficiency of biopharmaceutical processes. Amy's expertise in cross-functional team leadership allows her to effectively collaborate with diverse groups, ensuring that strategic and tactical objectives align with the organization's overarching goals.
Amy is particularly passionate about building high-performing teams, recognizing that the collective ambition and diverse experiences of team members can lead to transformative results. She is committed to fostering an inclusive environment where every voice is heard, enabling her teams to thrive and contribute to Merck's success. Her focus on process improvement and adherence to Standard Operating Procedures (SOP) ensures that the organization maintains high standards of quality and compliance, particularly in aseptic processing and change control.
Key projects under Amy's leadership include the implementation of robust business process improvement initiatives that streamline operations and enhance productivity. She has successfully led efforts to integrate Corrective and Preventive Actions (CAPA) into everyday practices, reinforcing a culture of continuous improvement. Amy's strategic vision and hands-on approach not only drive operational efficiencies but also empower her teams to embrace challenges and innovate solutions that meet the evolving needs of the pharmaceutical landscape. Through her leadership, Amy Baniewicz exemplifies the impact of passionate and dedicated professionals in shaping the future of biopharmaceutical engineering.
